Press release
Peptide Therapeutics Market: Trends, Opportunities and Forecasts 2020
The global market for peptide therapeutics has witnessed development at a significant pace in the past few years, observing a vast rise in the number of peptide drugs being approved and marketed in the global market. The constantly rising number of approvals of peptide-based medicines and the rising array of medical indications finding peptide drugs suitable for effective treatment have cemented the position of peptide therapeutics as one of the most promising fields of the pharmaceutical industry.
Download The Full Brouchre of Report: https://goo.gl/6Ab9sv
This report on the global peptide therapeutics market is a detailed analysis of the market, its key segments, and various factors influencing the overall development of the market as observed in the present scenario. As such, the report provides an analytical overview of factors such as growth drivers, challenges, key trends of the present and recent times, regulatory landscape of key regional markets, growth opportunities, and competitive scenario in the global peptide therapeutics market.
Global Peptide Therapeutics Market: Segmentation
The report segments the global peptide therapeutics market on the basis of criteria such as application, marketing status of key peptide drugs in the global market, route of administration, and geography.
On the basis of application, the global peptide therapeutics market has been further segmented into cancer, metabolic disorders, central nervous system disorders, cardiovascular disorders, hematological disorders, infection, acromegaly, respiratory disorders, and gastrointestinal disorders. Of these, cancer is presently the class of disease that rakes in the massive share in the revenue of the global peptide therapeutics market. In the near future, however, the segment of respiratory disorders is expected to emerge as the segment with the most promising growth opportunities.
On the basis of marketing status, the report further segments the market into the key branded peptide drugs approved by major regulatory authorities and available for sale in the global market. This segment includes an analysis of leading peptide-based drugs such as Zoladex, Angiomax, Copaxone, Velcade, Forteo, Victoza, and Sandostatin. These drugs are classified on the basis of their status as branded drugs and generic drugs. This section also presents a thorough analysis of the impact of generic peptide drugs on the overall development of the global peptide therapeutics market in the next few years.
On the basis of route of administration, the report segments the market into parenteral and oral. This segment provides the reader a thorough account of the key trends observed in the market related to course of administration of peptide-based drugs. One of the key trends in this area highlighted in the report includes the rising demand for drugs that are convenient to administer.
Global Peptide Therapeutics Market: Geographical and Competitive Dynamics
The report presents a detailed overview of the peptide therapeutics market across key regional markets including Asia Pacific, North America, Europe, and Middle East and Africa. Share and contribution of these regional markets on the revenue of the global market. Aspects such as the presence of key manufacturers, research bodies, growth opportunities, and regulatory aspects governing the peptide therapeutics market and its development in these regions are also analyzed. With the vast rise in prevalence of a large number of chronic diseases and the large population base, Asia Pacific has been highlighted as one of the most promising regions for the peptide therapeutics market.
The company profile section of the report includes a detailed overview of some of the leading players operating in the global peptide therapeutics market. As such, detailed profiles of companies such as CordenPharma International GmbH, Amgen, Inc., Bachem Holding AG, AstraZeneca plc, PolyPeptide Group, Eli Lilly & Co., Merck & Co., Lonza, Inc., Teva Pharmaceutical Industries Limited, Ipsen S.A., Novo Nordisk A/S, Novartis AG, Takeda Pharmaceutical Company Limited, Sanofi, and Roche Holdings AG are included.
Major regions analyzed under this research report are:
Europe
North America
Asia Pacific
Rest of the World
This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years
Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segments
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market: Trends, Opportunities and Forecasts 2020 here
News-ID: 491927 • Views: …
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview
The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the…
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise…
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market:
Introduction
Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for…
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.
Overview
Radiofrequency ablation is a minimally invasive surgical…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
